{
  "id": "lewy-body-dementia",
  "title": "Lewy Body Dementia",
  "version": "1.1",
  "icd10": [
    "** G31.83 (Dementia with Lewy bodies)",
    "F02.80 (Dementia in DLB without behavioral disturbance)",
    "F02.81 (Dementia in DLB with behavioral disturbance)"
  ],
  "scope": "** Diagnosis based on McKeith criteria (2017), biomarker-supported diagnosis (DaTscan, MIBG), symptomatic management of cognitive, motor, behavioral, and autonomic symptoms. Emphasizes neuroleptic sensitivity and safe treatment approaches. Covers both pure DLB and Parkinson's disease dementia (PDD) overlap.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential (CPT 85025)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Infection screen; anemia contributing to cognitive changes",
          "target": "Normal"
        },
        {
          "item": "BMP (CPT 80048)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hyponatremia, uremia, hypercalcemia as causes of confusion",
          "target": "Normal electrolytes, BUN, Cr"
        },
        {
          "item": "TSH (CPT 84443)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
          "target": "0.4-4.0 mIU/L"
        },
        {
          "item": "Vitamin B12 (CPT 82607)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Deficiency can cause cognitive impairment and parkinsonism",
          "target": ">300 pg/mL (>400 optimal)"
        },
        {
          "item": "Folate (CPT 82746)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Deficiency contributes to cognitive impairment",
          "target": ">3 ng/mL"
        },
        {
          "item": "Glucose (fasting) (CPT 82947)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Diabetes affects cognition and autonomic function",
          "target": "70-100 mg/dL"
        },
        {
          "item": "Hepatic panel (LFTs) (CPT 80076)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Baseline before medications; hepatic encephalopathy",
          "target": "Normal"
        },
        {
          "item": "Urinalysis (CPT 81001)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "UTI common cause of acute confusion in elderly",
          "target": "Negative for infection"
        }
      ],
      "Extended Workup (Second-line)": [
        {
          "item": "Vitamin D, 25-hydroxy (CPT 82306)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Deficiency associated with falls and cognitive decline",
          "target": ">30 ng/mL"
        },
        {
          "item": "Hemoglobin A1c (CPT 83036)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Chronic glucose control affects cognition",
          "target": "<7%"
        },
        {
          "item": "Lipid panel (CPT 80061)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Vascular risk factors",
          "target": "LDL <100 mg/dL"
        },
        {
          "item": "RPR or VDRL (CPT 86592)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Neurosyphilis (rare but treatable)",
          "target": "Nonreactive"
        },
        {
          "item": "HIV testing (CPT 87389)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "HIV-associated neurocognitive disorder",
          "target": "Negative"
        },
        {
          "item": "ESR (CPT 85651), CRP (CPT 86140)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Inflammatory/autoimmune causes",
          "target": "Normal"
        },
        {
          "item": "Cortisol (AM) (CPT 82533)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Adrenal insufficiency causing orthostatic hypotension",
          "target": "10-20 mcg/dL"
        }
      ],
      "Rare/Specialized (Refractory or Atypical)": [
        {
          "item": "CSF alpha-synuclein seed amplification assay (SAA) (CPT 83519)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Confirms synucleinopathy; research/atypical cases",
          "target": "Positive aggregation"
        },
        {
          "item": "Skin biopsy for phosphorylated alpha-synuclein (CPT 88305)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Peripheral synuclein deposition confirms synucleinopathy",
          "target": "Positive deposits in cutaneous nerves"
        },
        {
          "item": "Genetic testing (GBA, SNCA) (CPT 81479)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Family history or early-onset; GBA mutations increase DLB risk",
          "target": "Identifies genetic risk"
        },
        {
          "item": "Paraneoplastic antibody panel (CPT 86235)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Autoimmune dementia; rapid progression",
          "target": "Negative"
        },
        {
          "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2) (CPT 86255)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Autoimmune encephalitis if rapid onset",
          "target": "Negative"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "MRI Brain without contrast (CPT 70551)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "At initial evaluation",
          "target": "Relative preservation of medial temporal lobes (vs AD); rule out structural causes",
          "contraindications": "MRI-incompatible devices"
        },
        {
          "item": "CT Head non-contrast (CPT 70450)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If MRI unavailable",
          "target": "Rule out mass, hemorrhage, hydrocephalus",
          "contraindications": "None"
        }
      ],
      "Extended": [
        {
          "item": "DaTscan (ioflupane I-123 SPECT) (CPT 78607)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Diagnostic uncertainty; differentiating DLB from AD",
          "target": "Reduced dopamine transporter uptake in putamen (indicative biomarker)",
          "contraindications": "Hypersensitivity to iodine"
        },
        {
          "item": "Cardiac MIBG scintigraphy (CPT 78452)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Differentiate DLB from AD; supports diagnosis",
          "target": "Reduced cardiac uptake (indicative biomarker)",
          "contraindications": "Recent MI; drugs affecting uptake (labetalol, reserpine)"
        },
        {
          "item": "FDG-PET Brain (CPT 78816)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Differentiate from AD; atypical presentations",
          "target": "Posterior occipital hypometabolism with cingulate island sign (supportive biomarker)",
          "contraindications": "None"
        },
        {
          "item": "Polysomnography (CPT 95810)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "REM sleep behavior disorder confirmation",
          "target": "REM sleep without atonia (indicative biomarker)",
          "contraindications": "None"
        },
        {
          "item": "EEG (CPT 95819)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Encephalopathy; fluctuating cognition",
          "target": "Posterior slow-wave activity with periodic fluctuations (supportive)",
          "contraindications": "None"
        },
        {
          "item": "Autonomic function testing (CPT 95923)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Dysautonomia assessment",
          "target": "Orthostatic hypotension, abnormal HR variability",
          "contraindications": "None"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Amyloid PET (CPT 78816)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Atypical cases; AD co-pathology assessment",
          "target": "May be positive (AD-DLB overlap common)",
          "contraindications": "None"
        },
        {
          "item": "Tau PET (CPT 78816)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Research; differentiate from AD tauopathy",
          "target": "Less tau deposition than AD for similar dementia severity",
          "contraindications": "None"
        },
        {
          "item": "SPECT perfusion (CPT 78607)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Alternative to FDG-PET",
          "target": "Posterior hypoperfusion pattern",
          "contraindications": "None"
        },
        {
          "item": "MRI with SWI (CPT 70553)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Microbleeds; cerebral amyloid angiopathy",
          "target": "Lobar microbleed pattern",
          "contraindications": "MRI contraindications"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "AVOID TYPICAL ANTIPSYCHOTICS",
          "route": "-",
          "indication": "CRITICAL SAFETY WARNING",
          "dosing": {
            "doseOptions": [
              {
                "text": "DO NOT USE",
                "orderSentence": "AVOID TYPICAL ANTIPSYCHOTICS DO NOT USE N/A"
              }
            ],
            "route": "N/A",
            "instructions": "Haloperidol, chlorpromazine, fluphenazine absolutely contraindicated; risk of severe parkinsonism, NMS, and death",
            "orderSentence": "AVOID TYPICAL ANTIPSYCHOTICS DO NOT USE N/A"
          },
          "contraindications": "DLB is absolute contraindication",
          "monitoring": "N/A",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "AVOID MOST ATYPICAL ANTIPSYCHOTICS",
          "route": "-",
          "indication": "CRITICAL SAFETY WARNING",
          "dosing": {
            "doseOptions": [
              {
                "text": "DO NOT USE",
                "orderSentence": "AVOID MOST ATYPICAL ANTIPSYCHOTICS DO NOT USE N/A"
              }
            ],
            "route": "N/A",
            "instructions": "Risperidone, olanzapine, aripiprazole, ziprasidone contraindicated; 2-3x mortality risk",
            "orderSentence": "AVOID MOST ATYPICAL ANTIPSYCHOTICS DO NOT USE N/A"
          },
          "contraindications": "DLB is relative contraindication",
          "monitoring": "N/A",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Quetiapine (if antipsychotic absolutely needed)",
          "route": "PO",
          "indication": "Severe psychosis/agitation when non-pharmacologic fails",
          "dosing": {
            "doseOptions": [
              {
                "text": "12.5 mg",
                "orderSentence": "Quetiapine (if antipsychotic absolutely needed) 12.5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 12.5 mg qHS; increase slowly by 12.5 mg q3-7d; max 50-100 mg; lowest effective dose for shortest time",
            "orderSentence": "Quetiapine (if antipsychotic absolutely needed) 12.5 mg PO"
          },
          "contraindications": "QT prolongation",
          "monitoring": "Monitor for worsening parkinsonism, sedation",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Treat delirium triggers",
          "route": "Various",
          "indication": "Infection, metabolic, medication-induced delirium",
          "dosing": {
            "doseOptions": [
              {
                "text": "Per cause",
                "orderSentence": "Treat delirium triggers Per cause Various"
              }
            ],
            "route": "Various",
            "instructions": "Treat UTI, correct electrolytes, remove offending drugs (especially anticholinergics)",
            "orderSentence": "Treat delirium triggers Per cause Various"
          },
          "contraindications": "Depends on intervention",
          "monitoring": "Mental status",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Symptomatic Treatments": [
        {
          "item": "Rivastigmine oral",
          "route": "PO",
          "indication": "Cognitive impairment and visual hallucinations (FDA approved for PDD)",
          "dosing": {
            "doseOptions": [
              {
                "text": "1.5 mg",
                "orderSentence": "Rivastigmine oral 1.5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 1.5 mg BID with meals; increase by 1.5 mg BID q2-4wk; target 6 mg BID; may improve hallucinations",
            "orderSentence": "Rivastigmine oral 1.5 mg PO"
          },
          "contraindications": "Sick sinus syndrome; GI bleeding; severe hepatic impairment",
          "monitoring": "Nausea, weight loss, tremor worsening, bradycardia",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Rivastigmine patch",
          "route": "TD",
          "indication": "Cognitive impairment; better GI tolerability",
          "dosing": {
            "doseOptions": [
              {
                "text": "4.6 mg/24hr",
                "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
              }
            ],
            "route": "TD",
            "instructions": "Start 4.6 mg/24hr patch; increase q4wk; target 9.5-13.3 mg/24hr",
            "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
          },
          "contraindications": "Sick sinus syndrome; GI bleeding; severe hepatic impairment",
          "monitoring": "Skin irritation, nausea",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Donepezil",
          "route": "PO",
          "indication": "Cognitive impairment; alternative to rivastigmine",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Donepezil 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg qHS x 4-6 weeks; may increase to 10 mg qHS",
            "orderSentence": "Donepezil 5 mg PO"
          },
          "contraindications": "Sick sinus syndrome; GI bleeding; COPD exacerbation",
          "monitoring": "Bradycardia, vivid dreams (may worsen RBD), GI",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Galantamine",
          "route": "PO",
          "indication": "Cognitive impairment; alternative cholinesterase inhibitor",
          "dosing": {
            "doseOptions": [
              {
                "text": "4 mg",
                "orderSentence": "Galantamine 4 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 4 mg BID x 4wk; increase to 8 mg BID; target 8-12 mg BID",
            "orderSentence": "Galantamine 4 mg PO"
          },
          "contraindications": "Sick sinus syndrome; GI bleeding; COPD exacerbation; severe renal/hepatic impairment",
          "monitoring": "GI symptoms, bradycardia",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Memantine",
          "route": "PO",
          "indication": "Moderate-severe dementia; add to cholinesterase inhibitor",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Memantine 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg daily; increase by 5 mg/wk; target 10 mg BID",
            "orderSentence": "Memantine 5 mg PO"
          },
          "contraindications": "Severe renal impairment (dose adjust CrCl <30)",
          "monitoring": "Confusion, dizziness, constipation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Carbidopa-Levodopa",
          "route": "PO",
          "indication": "Motor parkinsonism symptoms",
          "dosing": {
            "doseOptions": [
              {
                "text": "25/100 mg",
                "orderSentence": "Carbidopa-Levodopa 25/100 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25/100 mg TID; titrate slowly; use lowest effective dose; may worsen hallucinations",
            "orderSentence": "Carbidopa-Levodopa 25/100 mg PO"
          },
          "contraindications": "Active psychosis",
          "monitoring": "Dyskinesias, confusion, hallucination worsening",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Melatonin",
          "route": "PO",
          "indication": "REM sleep behavior disorder (first-line)",
          "dosing": {
            "doseOptions": [
              {
                "text": "3 mg",
                "orderSentence": "Melatonin 3 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 3-6 mg 30 min before bed; may increase to 12 mg; first-line for RBD",
            "orderSentence": "Melatonin 3 mg PO"
          },
          "contraindications": "None",
          "monitoring": "Generally well-tolerated",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Clonazepam",
          "route": "PO",
          "indication": "REM sleep behavior disorder (second-line)",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.25 mg",
                "orderSentence": "Clonazepam 0.25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.25-0.5 mg qHS; typical 0.5-1 mg; use with caution due to sedation and fall risk",
            "orderSentence": "Clonazepam 0.25 mg PO"
          },
          "contraindications": "Severe sleep apnea; respiratory compromise; dementia (relative)",
          "monitoring": "Sedation, falls, cognitive worsening",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Pimavanserin (Nuplazid)",
          "route": "PO",
          "indication": "Visual hallucinations and psychosis",
          "dosing": {
            "doseOptions": [
              {
                "text": "34 mg",
                "orderSentence": "Pimavanserin (Nuplazid) 34 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "34 mg once daily; takes 4-6 weeks for effect; no titration; selective 5-HT2A inverse agonist",
            "orderSentence": "Pimavanserin (Nuplazid) 34 mg PO"
          },
          "contraindications": "Severe hepatic impairment; QT prolongation",
          "monitoring": "QTc at baseline; efficacy assessment 6 weeks",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Trazodone",
          "route": "PO",
          "indication": "Insomnia; sundowning",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg",
                "orderSentence": "Trazodone 25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25-50 mg qHS; titrate by 25 mg; typical 50-100 mg qHS",
            "orderSentence": "Trazodone 25 mg PO"
          },
          "contraindications": "MAOIs; QT prolongation",
          "monitoring": "Orthostatic hypotension",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Autonomic Dysfunction Treatments": [
        {
          "item": "Midodrine",
          "route": "PO",
          "indication": "Orthostatic hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5 mg",
                "orderSentence": "Midodrine 2.5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 2.5 mg TID (before arising, lunch, mid-afternoon); titrate by 2.5 mg/dose; max 10 mg TID; last dose by 6 PM",
            "orderSentence": "Midodrine 2.5 mg PO"
          },
          "contraindications": "Supine hypertension; urinary retention; severe cardiac disease",
          "monitoring": "Supine BP; avoid lying flat 4 hours after dose",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Droxidopa (Northera)",
          "route": "PO",
          "indication": "Neurogenic orthostatic hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg",
                "orderSentence": "Droxidopa (Northera) 100 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 100 mg TID; titrate by 100 mg/dose q24-48h; max 600 mg TID",
            "orderSentence": "Droxidopa (Northera) 100 mg PO"
          },
          "contraindications": "Supine hypertension",
          "monitoring": "Supine BP, headache",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Fludrocortisone",
          "route": "PO",
          "indication": "Orthostatic hypotension adjunct",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.1 mg",
                "orderSentence": "Fludrocortisone 0.1 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily",
            "orderSentence": "Fludrocortisone 0.1 mg PO"
          },
          "contraindications": "CHF; severe hypertension",
          "monitoring": "K+, edema, supine BP, weight",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Polyethylene glycol (MiraLAX)",
          "route": "PO",
          "indication": "Constipation",
          "dosing": {
            "doseOptions": [
              {
                "text": "17 g",
                "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
              }
            ],
            "route": "PO",
            "instructions": "17 g (1 capful) in 8 oz liquid daily; may increase to BID",
            "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
          },
          "contraindications": "Bowel obstruction",
          "monitoring": "Diarrhea if excessive",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Senna + docusate",
          "route": "PO",
          "indication": "Constipation stimulant",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 tablets",
                "orderSentence": "Senna + docusate 2 tablets PO"
              }
            ],
            "route": "PO",
            "instructions": "2 tablets qHS; may increase to 4 tablets",
            "orderSentence": "Senna + docusate 2 tablets PO"
          },
          "contraindications": "Bowel obstruction; undiagnosed abdominal pain",
          "monitoring": "Electrolytes with chronic use",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Tamsulosin",
          "route": "PO",
          "indication": "Urinary retention",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 mg",
                "orderSentence": "Tamsulosin 0.4 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "0.4 mg once daily 30 min after meal",
            "orderSentence": "Tamsulosin 0.4 mg PO"
          },
          "contraindications": "Known hypersensitivity; concurrent silodosin",
          "monitoring": "Orthostatic hypotension (caution with existing OH)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Oxybutynin",
          "route": "PO",
          "indication": "Urinary urgency (use with extreme caution)",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5 mg",
                "orderSentence": "Oxybutynin 2.5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "2.5 mg BID only; avoid higher doses; anticholinergic burden worsens cognition",
            "orderSentence": "Oxybutynin 2.5 mg PO"
          },
          "contraindications": "Narrow-angle glaucoma; urinary retention; dementia (relative)",
          "monitoring": "Cognitive worsening; dry mouth",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        }
      ],
      "Depression and Anxiety Treatments": [
        {
          "item": "Sertraline",
          "route": "PO",
          "indication": "Depression; anxiety",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg",
                "orderSentence": "Sertraline 25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg",
            "orderSentence": "Sertraline 25 mg PO"
          },
          "contraindications": "MAOIs",
          "monitoring": "GI upset; may worsen OH",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Escitalopram",
          "route": "PO",
          "indication": "Depression; anxiety",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Escitalopram 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg daily; may increase to 10 mg; max 10 mg in elderly (QT)",
            "orderSentence": "Escitalopram 5 mg PO"
          },
          "contraindications": "MAOIs; QT prolongation",
          "monitoring": "QTc; GI upset",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Venlafaxine XR",
          "route": "PO",
          "indication": "Depression; anxiety",
          "dosing": {
            "doseOptions": [
              {
                "text": "37.5 mg",
                "orderSentence": "Venlafaxine XR 37.5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 37.5 mg daily; titrate q1-2wk; typical 75-150 mg",
            "orderSentence": "Venlafaxine XR 37.5 mg PO"
          },
          "contraindications": "MAOIs",
          "monitoring": "BP at higher doses",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Mirtazapine",
          "route": "PO",
          "indication": "Depression with poor appetite and insomnia",
          "dosing": {
            "doseOptions": [
              {
                "text": "7.5 mg",
                "orderSentence": "Mirtazapine 7.5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg",
            "orderSentence": "Mirtazapine 7.5 mg PO"
          },
          "contraindications": "MAOIs",
          "monitoring": "Weight gain, sedation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Cognitive/behavioral neurology for diagnosis confirmation using McKeith criteria and treatment planning",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Movement disorders specialist if motor symptoms prominent or considering dopaminergic therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Neuropsychology for comprehensive cognitive testing to establish baseline and differentiate from AD",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Geriatric psychiatry for behavioral symptoms, medication management, and capacity evaluation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Sleep medicine for polysomnography to confirm REM sleep behavior disorder (indicative biomarker)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Physical therapy for gait training, balance exercises, and fall prevention",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Speech therapy for communication strategies and swallowing evaluation if dysphagia present",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Social work for caregiver support, community resources, and long-term care planning",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Palliative care for advanced dementia symptom management and goals of care discussions",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cardiology if orthostatic hypotension refractory to first-line treatment",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Patient Instructions": [
        {
          "item": "CRITICAL: Avoid all typical antipsychotics and most atypical antipsychotics - severe sensitivity can cause parkinsonism, rigidity, and death",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        },
        {
          "item": "Carry a medication alert card listing \"Lewy Body Dementia - Neuroleptic Sensitivity\" for all healthcare encounters",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report visual hallucinations immediately as these may indicate disease progression or medication effect",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Implement safety measures for REM sleep behavior disorder: padded bed rails, mattress on floor, remove sharp objects from bedside",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Complete advance directives while patient has capacity to document wishes for future care",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do not drive due to fluctuating attention, visual-spatial deficits, and hallucinations",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Return immediately if sudden worsening of confusion, falls, or inability to walk (may indicate medication effect or infection)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces due to high fall risk",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "AVOID medications that worsen symptoms: anticholinergics, antihistamines (diphenhydramine), sleep aids (Benadryl, Tylenol PM)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "AVOID antiemetics: metoclopramide, prochlorperazine, promethazine (D2 blocking worsens parkinsonism)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Regular physical exercise as tolerated to maintain mobility and reduce fall risk",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Structured daily routine with consistent sleep-wake times helps with fluctuating cognition",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Adequate lighting and avoid overstimulation which may trigger hallucinations",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Simplify environment and reduce visual clutter to minimize misperceptions",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Caregiver education about fluctuating cognition, which is characteristic and not willful",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Treat sleep apnea if present as it worsens cognition and autonomic dysfunction",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Alzheimer's disease",
      "features": "Memory impairment predominates; no parkinsonism; no visual hallucinations early",
      "tests": "DaTscan normal in AD; MRI hippocampal atrophy; amyloid/tau biomarkers"
    },
    {
      "diagnosis": "Parkinson's disease dementia (PDD)",
      "features": "Motor symptoms precede dementia by >1 year (vs DLB dementia within 1 year of motor)",
      "tests": "Clinical timeline; considered same disease spectrum as DLB"
    },
    {
      "diagnosis": "Vascular dementia",
      "features": "Stepwise decline; focal findings; executive dysfunction; vascular risk factors",
      "tests": "MRI with significant white matter disease, strategic infarcts"
    },
    {
      "diagnosis": "Frontotemporal dementia",
      "features": "Personality change; disinhibition; apathy; hyperorality; younger onset",
      "tests": "FDG-PET frontal hypometabolism; preserved posterior metabolism"
    },
    {
      "diagnosis": "Progressive supranuclear palsy (PSP)",
      "features": "Vertical gaze palsy; axial rigidity > limb; early falls backward; poor levodopa response",
      "tests": "MRI \"hummingbird sign\"; clinical criteria"
    },
    {
      "diagnosis": "Corticobasal syndrome",
      "features": "Asymmetric rigidity; apraxia; alien limb; cortical sensory loss",
      "tests": "MRI asymmetric cortical atrophy; clinical criteria"
    },
    {
      "diagnosis": "Multiple system atrophy (MSA)",
      "features": "Severe early dysautonomia; cerebellar signs; stridor; poor levodopa response",
      "tests": "MRI \"hot cross bun\" sign; cardiac MIBG preserved (vs reduced in DLB)"
    },
    {
      "diagnosis": "Creutzfeldt-Jakob disease",
      "features": "Rapid progression (weeks-months); myoclonus; periodic sharp waves on EEG",
      "tests": "EEG PSWCs; MRI DWI cortical ribboning; CSF RT-QuIC positive"
    },
    {
      "diagnosis": "Drug-induced parkinsonism",
      "features": "Medication exposure (antipsychotics, metoclopramide); symmetric; no hallucinations",
      "tests": "DaTscan normal; medication history; resolves with drug removal"
    },
    {
      "diagnosis": "Delirium",
      "features": "Acute onset; fluctuating attention; identifiable cause",
      "tests": "Treat cause; reassess cognition when clear"
    },
    {
      "diagnosis": "Charles Bonnet syndrome",
      "features": "Visual hallucinations with insight; occurs with visual impairment; no dementia",
      "tests": "Ophthalmologic evaluation; cognitive testing normal"
    }
  ],
  "evidence": [
    {
      "recommendation": "McKeith diagnostic criteria for DLB",
      "evidenceLevel": "Consensus Guidelines",
      "source": "[McKeith et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28592453/)"
    },
    {
      "recommendation": "DaTscan indicative biomarker for DLB",
      "evidenceLevel": "Class II, Level B",
      "source": "[McKeith et al. Lancet Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17362834/)"
    },
    {
      "recommendation": "Cardiac MIBG indicative biomarker",
      "evidenceLevel": "Class II, Level B",
      "source": "[Yoshita et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/26598877/)"
    },
    {
      "recommendation": "Rivastigmine for PDD/DLB cognition",
      "evidenceLevel": "Class I, Level A",
      "source": "[Emre et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15590953/)"
    },
    {
      "recommendation": "Donepezil for DLB",
      "evidenceLevel": "Class I, Level A",
      "source": "[Mori et al. Ann Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22829268/)"
    },
    {
      "recommendation": "Cholinesterase inhibitors reduce visual hallucinations",
      "evidenceLevel": "Class II, Level B",
      "source": "[Stinton et al. Int J Geriatr Psychiatry 2015](https://pubmed.ncbi.nlm.nih.gov/26085043/)"
    },
    {
      "recommendation": "Neuroleptic sensitivity in DLB",
      "evidenceLevel": "Class II, Level B",
      "source": "[McKeith et al. BMJ 1992](https://pubmed.ncbi.nlm.nih.gov/1356550/)"
    },
    {
      "recommendation": "Antipsychotic mortality risk in dementia",
      "evidenceLevel": "Class I, Level A",
      "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16234500/)"
    },
    {
      "recommendation": "Pimavanserin for PD psychosis",
      "evidenceLevel": "Class I, Level A",
      "source": "[Cummings et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24183563/)"
    },
    {
      "recommendation": "Melatonin for REM sleep behavior disorder",
      "evidenceLevel": "Class II, Level B",
      "source": "[Kunz et al. Sleep Med 2010](https://pubmed.ncbi.nlm.nih.gov/21619862/)"
    },
    {
      "recommendation": "Clonazepam for REM sleep behavior disorder",
      "evidenceLevel": "Class II, Level B",
      "source": "[Aurora et al. Sleep 2010](https://pubmed.ncbi.nlm.nih.gov/21061864/)"
    },
    {
      "recommendation": "CSF alpha-synuclein SAA for synucleinopathies",
      "evidenceLevel": "Class II, Level B",
      "source": "[Siderowf et al. Lancet Neurol 2023](https://pubmed.ncbi.nlm.nih.gov/37863605/)"
    }
  ],
  "monitoring": [
    {
      "item": "Cognitive function (MoCA or MMSE)",
      "frequency": "Every 6 months",
      "action": "Adjust treatment; reassess diagnosis",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Motor function (UPDRS-III)",
      "frequency": "Every 6 months",
      "action": "Adjust levodopa if motor symptoms dominant",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Visual hallucinations frequency/severity",
      "frequency": "Each visit",
      "action": "Adjust cholinesterase inhibitor; add pimavanserin if distressing",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Orthostatic blood pressure",
      "frequency": "Each visit",
      "action": "Add midodrine or droxidopa",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Falls frequency",
      "frequency": "Each visit",
      "action": "PT referral; medication review; home safety",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "RBD symptoms",
      "frequency": "Each visit",
      "action": "Adjust melatonin or clonazepam; safety measures",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Mood (GDS, PHQ-9)",
      "frequency": "Every 6 months",
      "action": "Add antidepressant; psychiatry referral",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "ADL/IADL function",
      "frequency": "Every 6 months",
      "action": "Increase support services; OT referral",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Caregiver burden (Zarit scale)",
      "frequency": "Every 6-12 months",
      "action": "Support resources; respite care; social work",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Weight",
      "frequency": "Each visit",
      "action": "Nutritional assessment; speech for swallowing",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "ECG (if on pimavanserin, citalopram)",
      "frequency": "Baseline; if dose increased",
      "action": "Reduce dose or switch agent",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    }
  ],
  "disposition": [
    {
      "disposition": "Discharge home",
      "criteria": "Reversible causes treated; safe environment; caregiver support; no acute behavioral crisis; follow-up arranged"
    },
    {
      "disposition": "Admit to floor",
      "criteria": "Acute delirium requiring workup; severe behavioral crisis unsafe for home; falls with injury; medication toxicity"
    },
    {
      "disposition": "Admit to psychiatry",
      "criteria": "Severe behavioral disturbance requiring specialized psychiatric management; suicidal ideation"
    },
    {
      "disposition": "Outpatient follow-up",
      "criteria": "Neurology/geriatrics 1-2 months after diagnosis; then every 3-6 months"
    },
    {
      "disposition": "Long-term care",
      "criteria": "Progressive decline; caregiver unable to manage safely; nocturnal behavioral disturbance; 24-hour supervision needed"
    }
  ]
}